CD24 and Parkinson disease: For instance, with glycoprotein CD24 being a potential marker of cell populations affected in PD [116], the engineering of exosomes with both a membrane protein fused to a humanized anti-CD24 scFv and Nefmut-anti-ND scFv would ensure precise targeting of the therapeutic scFv to CD24-expressing cells.